3 results
* To compare TKI258 vs. sorafenib with respect to progression-free survival (PFS) determined by central radiology assessment in patients with metastatic renal cell cancer (mRCC) after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor)…
Introduction of dovitinib in the neo-adjuvant setting, can provide both clinical informationabout it*s activity in patients with HCC (reduction of tumor size, influence on the tumor bloodflow as assessed by CT perfusion imaging) and (histo-)…
1. The primary objective of this study is to confirm the utility of the oVEMP cross-sectionally for the diagnosis of MG by reproducing the findings of Valko et al. in our cohort of MG patients and three control groups: healthy controls, controls…